市場調査レポート

商品コード

1801256

質量分析の世界市場 - 市場規模、シェア、動向、予測：技術別、アプリケーション別、地域別、2025年～2033年

Mass Spectrometry Market Size, Share, Trends and Forecast by Technology, Application, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

質量分析の世界市場規模は2024年に69億3,000万米ドルとなりました。2033年には117億2,000万米ドルに達すると予測され、2025～2033年のCAGRは5.72%です。現在、北米が市場を独占しており、2024年には約41.7％の大きな市場シェアを占めています。同市場は、製薬、バイオテクノロジー、食品安全産業における精密かつ迅速な分析手法への需要によって活性化しています。さらに、医薬品開発・発見への投資の増加と慢性疾患の増加により、プロテオミクス、メタボロミクス、臨床診断への質量分析の採用が加速しています。さらに、ハイブリッドスペクトロメトリー技術と自動化技術の向上が装置の機能性を向上させ、質量分析の市場シェアをさらに拡大しています。

同市場は、高分解能装置と強化されたイオン化技術における継続的な進歩が大きな影響を及ぼしており、その結果、各分野でより広範な利用が促されています。さらに、環境汚染や微量レベルの検出に対する懸念が、食品検査や水質モニタリングへの展開を強めています。2025年1月に発表された調査では、GC MS、LC MS/MS、高分解能ハイブリッドシステムを含む質量分析が、水、土壌、大気をマトリックスとする新興環境汚染物質の微量レベルのモニタリングにおいて極めて重要な役割を果たしていることが強調されています。水中の残留医薬品の検出限界は1.13-5.45 ng L-1と低く、揮発性有機化合物のリアルタイム検出と高分解能プラットフォームが可能にする非標的スクリーニング機能を強調しています。また、医薬品パイプラインの拡大とバイオ医薬品研究の急増により、精密な分子特性評価が必要とされており、需要をさらに後押ししています。

米国では、個別化医療と遺伝子研究が重視されるようになり、詳細な分子プロファイリングツールへの要求が高まっていることが市場を牽引しています。さらに、新たな市場動向の一つとして、連邦政府による生物医学・臨床研究への多額の資金援助があり、機器の大幅なアップグレードが維持されています。業界レポートによると、国立衛生研究所（NIH）は毎年470億米ドル以上を投資しており、健康、医学、行動学の研究に対する世界最大の公的資金源となっています。また、食品表示や残留農薬に関する厳しい規制が、農業や食品検査機関の採用を後押ししています。加えて、高度な法医学プロトコルの開発と国土安全保障対策の強化が、正確な検出装置の取得を機関に促しています。また、メタボロミクスとリピドミクスのワークフローに質量分析を統合することで、研究の奥行きが広がります。さらに、大手メーカーの強固なプレゼンスと利用しやすい技術サポートが、全国のラボへの継続的な投資を後押ししています。

質量分析市場の動向：

技術の進歩

継続的な技術進歩が市場の成長に大きく寄与しています。より高い感度、より優れた精度、迅速な処理能力といった最先端の改良により、これらの機器は現代の検査室に不可欠なものとなっています。さらに、技術の進歩により、ますます複雑化するサンプルの分析など、質量分析機器の機能が拡大しています。さらに、高分解能質量分析やタンデム質量分析のような、これまでにないレベルの詳細さと分析深度を提供する最近の技術革新が、市場の成長を支えています。さらに、即時のデータ収集と解釈を可能にするリアルタイムモニタリング機能の搭載が、質量分析市場の成長を強化しています。さらに、装置の小型化により、現場での分析に使用できるポータブルユニットが開発され、市場開拓を後押ししています。2025年3月、908 Devicesはウクライナ保健省から、戦後の環境検査用に有害物質や爆発物を検出するMX908ハンドヘルド質量分析計を170万米ドルで受注しており、ポータブル・ソリューションに対する需要の高まりを強調しています。

品質管理に対する厳しい規制方針

医薬品や食品安全などの産業における品質管理に対する規制要件が市場拡大を後押ししています。規制当局による厳格な基準の導入により、不純物の検出、製品の品質保証、プロセスの検証において、高い精度と感度を持つ質量分析に信頼を寄せる企業が増えています。さらに、質量分析は、化合物が純度基準を満たし、極めて低い濃度で汚染物質が検出されることを保証します。2025年4月、BrukerはRECIPE社の株式の過半数を取得しました。RECIPE社はミュンヘンを拠点とする臨床MSキットプロバイダーで、従業員60名、売上高1,500万米ドルを誇り、ハイスループットの「クロムフリー」ClinDART TDMアッセイを推進しています。さらに、農薬や毒素、その他の汚染物質がないことを保証するために、食品産業で広く技術が利用されていることが、市場の成長を後押ししています。さらに、このような規制上の義務により、質量分析は単なるオプションではなく、製品開発や製造プロセスにおける品質保証のために必要不可欠なものとなっています。

個別化医療への注目の高まり

個別化医療への注目が高まっていることも、質量分析市場の見通しにプラスの影響を与えている重要な要因です。ある業界レポートによると、FDAは300以上の個別化医薬品を承認しており、新薬の約25％がバイオマーカーデータと関連しています。ヘルスケアは個々の患者に合わせたものになりつつあり、その結果、詳細な分子・遺伝子情報の需要が高まっています。質量分析は、バイオマーカー、代謝物、タンパク質を分子レベルで解析する機能を提供し、プロテオミクスやゲノミクス研究において重要な役割を果たします。これらの知見は、個人の健康プロファイルを理解し、疾患感受性を予測し、それに応じて治療を調整するために極めて重要です。さらに、個別化医療の台頭により、医療プロバイダーや研究機関は、正確で患者に特化したデータの需要に対応するため、調査技術への投資を進めています。その結果、個別化医療への注目は、既存市場での質量分析の応用を後押しするだけでなく、医学の新たな分野への参入を開拓しています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第9章 SWOT分析

第10章バリューチェーン分析

第11章ポーターのファイブフォース分析

第12章価格分析

第13章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Agilent Technologies Inc.
- Bruker
- Danaher Corporation
- JEOL Ltd.
- Kore Technology Ltd.
- LECO Corporation
- PerkinElmer Inc.
- Rigaku Corporation
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation

図表

List of Figures

Figure 1: Global: Mass Spectrometry Market: Major Drivers and Challenges
Figure 2: Global: Mass Spectrometry Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Mass Spectrometry Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Mass Spectrometry Market: Breakup by Technology (in %), 2024
Figure 5: Global: Mass Spectrometry Market: Breakup by Application (in %), 2024
Figure 6: Global: Mass Spectrometry Market: Breakup by Region (in %), 2024
Figure 7: Global: Mass Spectrometry (Triple Quadrupole- Tandem) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Mass Spectrometry (Triple Quadrupole- Tandem) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Mass Spectrometry (Quadrupole TOF- Q-TOF) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Mass Spectrometry (Quadrupole TOF- Q-TOF) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Mass Spectrometry (FTMS- Fourier Transform Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Mass Spectrometry (FTMS- Fourier Transform Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Mass Spectrometry (Quadrupole) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Mass Spectrometry (Quadrupole) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Mass Spectrometry (Time-of-Flight- TOF) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Mass Spectrometry (Time-of-Flight- TOF) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Mass Spectrometry (ION Trap) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Mass Spectrometry (ION Trap) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Mass Spectrometry (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Mass Spectrometry (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Mass Spectrometry (Pharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Mass Spectrometry (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Mass Spectrometry (Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Mass Spectrometry (Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Mass Spectrometry (Chemical and Petrochemicals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Mass Spectrometry (Chemical and Petrochemicals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Mass Spectrometry (Environmental Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Mass Spectrometry (Environmental Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Mass Spectrometry (Food & Beverage Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Mass Spectrometry (Food & Beverage Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Mass Spectrometry (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Mass Spectrometry (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: North America: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: North America: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: United States: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: United States: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Canada: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Canada: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Asia-Pacific: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Asia-Pacific: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: China: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: China: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Japan: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Japan: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: India: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: India: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: South Korea: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: South Korea: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Australia: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Australia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Indonesia: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Indonesia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Europe: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Europe: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Germany: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Germany: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: France: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: France: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: United Kingdom: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: United Kingdom: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Italy: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Italy: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Spain: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Spain: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Russia: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Russia: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Latin America: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Latin America: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Brazil: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Brazil: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Mexico: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Mexico: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Middle East and Africa: Mass Spectrometry Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Middle East and Africa: Mass Spectrometry Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Middle East and Africa: Mass Spectrometry Market: Breakup by Country (in %), 2024
Figure 82: Global: Mass Spectrometry Industry: SWOT Analysis
Figure 83: Global: Mass Spectrometry Industry: Value Chain Analysis
Figure 84: Global: Mass Spectrometry Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Mass Spectrometry Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Mass Spectrometry Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Mass Spectrometry Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Mass Spectrometry Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Mass Spectrometry Market: Competitive Structure
Table 6: Global: Mass Spectrometry Market: Key Players

Product Code: SR112025A3341

The global mass spectrometry market size was valued at USD 6.93 Billion in 2024. The market is projected to reach USD 11.72 Billion by 2033, exhibiting a CAGR of 5.72% during 2025-2033. North America currently dominates the market, holding a significant market share of around 41.7% in 2024. The market is fueled by the demand for precise and fast analytical methods in the pharmaceutical, biotechnology, and food safety industries. Moreover, increased investments in drug development and discovery, combined with the rising incidences of chronic diseases, are accelerating the adoption of mass spectrometry for proteomics, metabolomics, and clinical diagnostics. Furthermore, improvements in hybrid spectrometry technology and automation are improving instrument functionality, further augmenting the mass spectrometry market share.

The market is majorly influenced by the continuous advancements in high-resolution instrumentation and enhanced ionization techniques, which are encouraging wider use across sectors. Moreover, concerns over environmental contamination and trace-level detection have intensified deployment in food testing and water quality monitoring. A research study published in January 2025 highlights the pivotal role of mass spectrometry, including GC MS, LC MS/MS, and high resolution hybrid systems, in monitoring trace levels of emerging environmental contaminants across water, soil, and air matrices. It reports detection limits as low as 1.13-5.45 ng L-1 for pharmaceutical residues in water and emphasizes real time detection of volatile organic compounds and non targeted screening capabilities enabled by high resolution platforms. Also, expanding pharmaceutical pipelines and the surge in biopharmaceutical research require precise molecular characterization, further supporting demand.

In the United States, the market is driven by the growing emphasis on personalized medicine and genetic studies, which increases the requirement for detailed molecular profiling tools. Furthermore, one of the emerging mass spectrometry market trends is the substantial federal funding for biomedical and clinical research sustaining significant equipment upgrades. As per industry reports, the National Institutes of Health (NIH) invests over USD 47 Billion each year, making it the world's biggest public source of funding for research in health, medicine, and behavior. Besides, strict regulations for food labeling and pesticide residue drive adoption among agricultural and food testing labs. In addition, the development of advanced forensic protocols and heightened homeland security measures pushes agencies to acquire precise detection equipment. Also, integration of mass spectrometry into metabolomics and lipidomics workflows enhances research depth. Additionally, the robust presence of leading manufacturers and accessible technical support boosts continuous laboratory investments nationwide.

Mass Spectrometry Market Trends:

Technological Advancements

Continuous technological advancements are significantly contributing to the growth of the market. Cutting-edge improvements, such as higher sensitivity, better accuracy, and rapid throughput, are making these instruments indispensable in modern laboratories. Furthermore, technological progress is expanding the capabilities of mass spectrometry instruments to include the analysis of increasingly complex samples. Additionally, recent innovations like high-resolution mass spectrometry and tandem mass spectrometry that are providing unprecedented levels of detail and analytical depth are supporting the market growth. Moreover, the incorporation of real-time monitoring capabilities, allowing immediate data collection and interpretation, is strengthening the mass spectrometry market growth. In addition, the miniaturization of these devices is leading to the creation of portable units that can be employed for on-site analysis, thereby favoring the market development. As such, in March 2025, 908 Devices received a USD 1.7 Million order from Ukraine's Ministry of Health for MX908 handheld mass spectrometers to detect hazardous substances and explosives for post-war environmental testing, highlighting the growing demand for portable solutions.

Strict Regulatory Policies for Quality Control

Regulatory requirements for quality control in industries, such as pharmaceuticals and food safety, are propelling the market expansion. The introduction of stringent standards by regulatory agencies is prompting companies to rely on mass spectrometry for its high degree of accuracy and sensitivity in detecting impurities, ensuring product quality, and validating processes. In addition, mass spectrometry ensures that compounds meet purity standards and that contaminants are detected at extremely low concentrations. Accordingly, in April 2025, Bruker acquired a majority stake in RECIPE, a Munich-based clinical MS kit provider with 60 employees and USD 15 Million revenue, advancing high-throughput 'chrom-free' ClinDART TDM assays. Furthermore, the widespread technology utilization in the food industry to ensure the absence of pesticides, toxins, and other contaminants is favoring the market growth. Moreover, these regulatory compulsions make mass spectrometry not just an option but a necessity for quality assurance in product development and manufacturing processes.

Growing Focus on Personalized Medicine

The growing emphasis on personalized medicine is another pivotal factor positively impacting the mass spectrometry market outlook. An industry report noted that the FDA approved over 300 personalized medicines, with about 25% of new drugs linked to biomarker data, and personalized strategies now make up over 40% of major pharma pipelines. Healthcare is becoming increasingly tailored to individual patients, resulting in a higher demand for detailed molecular and genetic information. Mass spectrometry provides the capability to analyze biomarkers, metabolites, and proteins at a molecular level, thereby playing a significant role in proteomics and genomics research. These insights are crucial for understanding individual health profiles, predicting disease susceptibility, and tailoring treatments accordingly. Furthermore, the rise in personalized medicine is pushing healthcare providers and research institutions to invest in mass spectrometry technologies to keep up with the demand for precise, patient-specific data. As a result, the focus on personalized healthcare is not only boosting the application of mass spectrometry in existing markets but is also pioneering its entry into new avenues of medical science.

Mass Spectrometry Industry Segmentation:

Analysis by Technology:

Triple Quadrupole (Tandem)
Quadrupole TOF (Q-TOF)
FTMS (Fourier Transform Mass Spectrometry)
Quadrupole
Time-of-Flight (TOF)
ION Trap
Others

Triple quadrupole (tandem) leads the market with around 37.5% of market share in 2024.Triple quadrupole systems offer high sensitivity and selectivity, making them ideal for detecting low-abundance analytes in complex samples. Furthermore, they are versatile and can be applied to various fields, such as proteomics, metabolomics, pharmaceuticals, and environmental analysis. This multi-disciplinary application range contributes to their widespread adoption. Besides this, triple quadrupole mass spectrometers excel in quantitative measurements, as they provide excellent repeatability and accuracy, which are crucial in sectors like drug development and diagnostics. Additionally, these systems are often compatible with various ionization techniques and chromatography systems, allowing for broader applications and easier integration into existing workflows. Moreover, triple quadrupole meets or exceeds the stringent regulations and quality standards required in many industries, which makes them a safer investment for compliance-conscious organizations.

Analysis by Application:

Pharmaceuticals
Biotechnology
Chemical and Petrochemicals
Environmental Testing
Food and Beverage Testing
Others

Pharmaceuticals lead the market in 2024. Pharmaceuticals are governed by strict regulatory standards. In line with this, mass spectrometry is invaluable for quality control and compliance, ensuring that pharmaceutical products meet these rigorous benchmarks. Furthermore, mass spectrometry is critical in the various stages of drug discovery, including target identification, screening, and pharmacokinetics. It provides accurate and precise data that aid researchers in the identification and quantification of compounds, thereby accelerating the time-to-market for new drugs. Besides this, mass spectrometry offers the high sensitivity and specificity required for proteomic and genomic studies, thereby driving its adoption in the pharmaceutical sector. Additionally, it is extensively used in metabolomics to identify and quantify metabolites, thus offering valuable insights into drug metabolism. Moreover, mass spectrometry is routinely used for quality control and batch-to-batch verification of raw materials, intermediates, and finished products.

Regional Analysis:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

In 2024, North America accounted for the largest market share of over 41.7%. North America hosts some of the world's leading research institutions and laboratories, which contributes to a high demand for mass spectrometry equipment for advanced research. Additionally, various government agencies are offering substantial grants and funding options for research and development (R&D) activities, including those that require mass spectrometry, thus fostering a favorable environment for market growth. Besides this, North America is the headquarters for numerous companies that are market leaders in the mass spectrometry segment. Moreover, the region is at the forefront of technological innovation in advanced mass spectrometry techniques like time-of-flight (TOF) and orbitrap. In addition to this, the presence of a robust healthcare system, coupled with the focus on precision medicine and diagnostics in the region, is further boosting the market growth.

Key Regional Takeaways:

United States Mass Spectrometry Market Analysis

In 2024, the United States holds a substantial share of around 87.50% of the mass spectrometry market share in North America. The market in the United States is primarily driven by strong investments in biomedical research, which are expanding applications in precision medicine and personalized healthcare. According to the World Health Organization (WHO), approximately 88% of all biomedical research grants, amounting to nearly USD 33 Billion, were awarded to organizations based in the United States. In line with this, the rapid integration of high-resolution mass spectrometry in clinical diagnostics, which facilitates the early detection of diseases and therapeutic drug monitoring, is driving market growth. The rise in biopharmaceutical manufacturing is further propelling demand for advanced analytical systems to ensure quality control and regulatory compliance. Similarly, increasing government fundings for environmental monitoring, which encourages the widespread deployment of pollutant and toxin analysis, is fostering market expansion. The rising focus on food safety testing for contaminants and residues is driving additional market appeal. Additionally, the expansion of forensic and crime laboratories is stimulating the use of portable and high-throughput mass spectrometry solutions. Apart from this, continuous innovations in hybrid and tandem systems, which reinforces U.S. leadership in analytical research capabilities, is expanding the market scope.

Europe Mass Spectrometry Market Analysis

The European market is experiencing growth due to strong investments in life sciences infrastructure, supported by national and EU-level funding initiatives. In accordance with this, the growing demand for advanced analytical techniques to meet stringent EU environmental regulations is driving market expansion. Similarly, rising investment in precision medicine and oncology programs, transforming the clinical diagnostics landscape, is expanding market reach. As such, in 2024, Berlin-based AI company Aignostics raised €31.4 million in Series B funding to enhance precision medicine through AI-driven pathology insights. The round was led by ATHOS, with investments from Mayo Clinic, HTGF, and other existing investors. The heightened need for food authenticity testing and contaminant traceability driving the deployment of high-resolution systems is supporting market demand. Additionally, the emerging trend of cross-border research collaborations, which encourages the adoption of interoperable, standardized analytical platforms, is stimulating market accessibility. The rapid expansion of biopharmaceutical pipelines and biologics manufacturing hubs is driving a significant increase in the market appeal. Besides this, Europe's expanding network of accredited testing facilities and the emphasis on laboratory automation are further providing an impetus to the regional market.

Asia Pacific Mass Spectrometry Market Analysis

The mass spectrometry market in the Asia Pacific is largely driven by rising government investments in precision medicine and genomic research. Furthermore, the growth of pharmaceutical manufacturing hubs in India and China, which drives demand for high-performance analytical instruments, is propelling market expansion. Similarly, increased collaborations between academic institutions and biotech companies, which foster innovation in biomarker discovery and proteomics, are strengthening market demand. The heightened adoption of stricter environmental monitoring standards is promoting the deployment of highly sensitive detection technologies. Additionally, the region's intensified focus on food safety testing is accelerating the use of mass spectrometry in the agro-food sector. Moreover, increasing funding for research and development is promoting the adoption of advanced mass spectrometry solutions in Asia Pacific healthcare and public health laboratories. Accordingly, in 2024, the National Natural Science Foundation of China (NSFC) and the U.S. NSF funded joint projects on infectious disease ecology and evolution, offering up to RMB 4.5 Million (about USD 630,000) per research project and RMB 1 Million (about USD 140,000) per exchange project, encouraging new international networks.

Latin America Mass Spectrometry Market Analysis

In Latin America, the market is growing due to increasing government investments in public health surveillance and advanced disease diagnostics. Similarly, the expansion of precision medicine programs is driving demand for high-resolution analytical tools to support the discovery of biomarkers and the development of targeted therapies. As such, in April 2025, MGI expanded its partnership with Brazil's Fiocruz to boost epidemiological surveillance and personalized medicine, equipping UNADIG's labs with advanced sequencers to process 2,000 genetic samples weekly and 29,000 clinical samples daily. The increasing emphasis on environmental monitoring and food safety regulations is driving the deployment of advanced mass spectrometry instruments for the detection of pollutants and quality control. Furthermore, expanding collaborations between local institutions and global pharmaceutical companies are driving technology transfer, advancing innovation, and broadening the market scope.

Middle East and Africa Mass Spectrometry Market Analysis

The mass spectrometry market in the Middle East and Africa is expanding due to increasing investments in healthcare infrastructure and advanced diagnostic capabilities across leading GCC nations. Furthermore, a heightened regulatory focus on food safety and environmental monitoring is driving the adoption of high-performance mass spectrometry in laboratories and testing centers. Similarly, collaborative research partnerships between regional universities and global analytical technology providers are supporting knowledge transfer and developing local expertise. Moreover, the region's growing pharmaceutical manufacturing sector is driving demand for precise analytical tools to ensure quality control, drug safety, and compliance with international standards, thereby providing an impetus to the market. Accordingly, in May 2025, Julphar announced a five-year investment plan of AED 300 Million (about USD 81 Million) to expand manufacturing, enhance technology, and encourage UAE pharmaceutical exports to over 40 global markets.

Competitive Landscape:

The competition in the market is intense, driven by continuous technological innovations and the growing requirement for accurate, dependable analytical solutions in a variety of industries. Firms in this market concentrate on creating hybrid platforms, miniaturized instruments, and user-friendly software interfaces to improve their competitive advantage. In addition, rigorous regulatory standards and increasing demand for sophisticated analytical capability across pharmaceutical development, food safety, and environmental testing drive ongoing investment in research and development (R&D). Besides, end users now place significant value on integrated systems that deliver accurate, complex analyses with minimal manual intervention, resulting in a greater emphasis on automation and ease of operation. Also, the demand for portable and high-throughput instruments is rising, driven by laboratories seeking to improve turnaround times and cost efficiency. According to the mass spectrometry market forecast, expanding applications in personalized medicine, proteomics, and metabolomics are expected to further accelerate the need for sophisticated mass spectrometry systems.

The report provides a comprehensive analysis of the competitive landscape in the mass spectrometry market with detailed profiles of all major companies, including:

Agilent Technologies Inc.
Bruker
Danaher Corporation
JEOL Ltd.
Kore Technology Ltd.
LECO Corporation
PerkinElmer Inc.
Rigaku Corporation
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation

Key Questions Answered in This Report

1.How big is the mass spectrometry market?
2.What is the future outlook of the mass spectrometry market?
3.What are the key factors driving the mass spectrometry market?
4.Which region accounts for the largest mass spectrometry market?
5.Which are the leading companies in the global mass spectrometry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Mass Spectrometry Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Technology

6.1 Triple Quadrupole (Tandem)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Quadrupole TOF (Q-TOF)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 FTMS (Fourier Transform Mass Spectrometry)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Quadrupole
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Time-of-Flight (TOF)
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 ION Trap
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast

7 Market Breakup by Application

7.1 Pharmaceuticals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Biotechnology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Chemical and Petrochemicals
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Environmental Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Food & Beverage Testing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Agilent Technologies Inc.
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Bruker
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Danaher Corporation
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 JEOL Ltd.
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Kore Technology Ltd.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
- 13.3.6 LECO Corporation
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
- 13.3.7 PerkinElmer Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Rigaku Corporation
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
- 13.3.9 Shimadzu Corporation
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Thermo Fisher Scientific Inc.
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis
- 13.3.11 Waters Corporation
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
  - 13.3.11.3 Financials
  - 13.3.11.4 SWOT Analysis

質量分析の世界市場 - 市場規模、シェア、動向、予測：技術別、アプリケーション別、地域別、2025年～2033年

Mass Spectrometry Market Size, Share, Trends and Forecast by Technology, Application, and Region, 2025-2033

質量分析市場の動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の質量分析市場

第6章 市場内訳：技術別

第7章 市場内訳：アプリケーション別

第8章 市場内訳：地域別

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

第12章 価格分析

第13章 競合情勢